BeStock  
Stocks › Biotechnology › EXEL

Exelixis EXEL

US equityMarket cap rank #1070Biotechnology
$64.63 −$1.20 (-1.82%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $64.63 0.00%
Open$65.95
Prev close$65.83
Day range$64.45 – $66.94
Volume2.19M
Market cap$15.77B
P/E (TTM)19.4
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings19.4x
CheapRich

Below its usual level · 32nd percentile, 5-year average 28.0x

#1665 of 2996 stocks by PE (1 = cheapest)

Price / book8.6x
CheapRich

Near the top of its 5-year range · 98th percentile, 5-year average 4.0x

#4922 of 5338 stocks by PB (1 = cheapest)

Price / sales6.3x
CheapRich

Near the top of its 5-year range · 98th percentile, 5-year average 4.4x

#4244 of 5161 stocks by PS (1 = cheapest)

P/E over five years

8x35x62x88xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$66.09
Price vs. fair value-2.2%Close to the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 8.60 – 3.96 98% (pricier than usual) #4922 of 5338 (1 = cheapest)
PE 19.35 15.87 27.98 32% (cheaper than usual) #1665 of 2996 (1 = cheapest)
PS 6.32 5.63 4.40 98% (pricier than usual) #4244 of 5161 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on EXEL.

Sign in to join the discussion.

Scroll to Top